CLPT

9.10

5.08% 0.44

Dopo l'orario di chiusura: 9.08 -0.02 -0.22%

Clearpoint Neuro Inc (CLPT)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

$8.66

Aprire:

$8.85

Volume 24 ore:

471.01K

Relative Volume:

0.60

Capitalizzazione di mercato:

$269.94M

Reddito:

$36.97M

Utile/perdita netta:

$-25.54M

Rapporto P/E:

-10.09

EPS:

-0.9022

Flusso di cassa netto:

$-24.45M

1 W Prestazione:

-3.40%

1M Prestazione:

-27.61%

6M Prestazione:

-58.24%

1 anno Prestazione:

-23.47%

Intervallo 1D:

$8.7263

$9.22

Intervallo di 1 settimana:

$8.595

$9.90

Portata 52W:

$8.595

$30.10

Clearpoint Neuro Inc Stock (CLPT) Company Profile

Nome

Clearpoint Neuro Inc

Settore

Healthcare (1114)

Industria

Medical Devices (143)

Telefono

(949) 900-6833

Indirizzo

120 S. SIERRA AVENUE, SOLANA BEACH, CA

Dipendente

172

Cinguettio

@intent

Prossima data di guadagno

2026-03-17

Ultimi documenti SEC

CLPT's Discussions on Twitter

Compare CLPT vs ABT, SYK, MDT, BSX, EW

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
CLPT Clearpoint Neuro Inc	9.10	256.89M	36.97M	-25.54M	-24.45M	-0.9022
ABT Abbott Laboratories	102.67	177.03B	44.33B	6.50B	7.40B	3.717
SYK Stryker Corp	328.59	124.89B	25.12B	3.25B	4.28B	8.3984
MDT Medtronic Plc	86.65	110.08B	35.48B	4.64B	5.41B	3.582
BSX Boston Scientific Corp	62.75	93.53B	20.08B	2.89B	3.66B	1.9391
EW Edwards Lifesciences Corp	80.08	45.84B	6.07B	1.06B	1.34B	1.8063

Clearpoint Neuro Inc Stock (CLPT) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-07-25	Ripresa	B. Riley Securities	Buy
2023-10-24	Iniziato	Stifel	Buy
2023-02-16	Ripresa	B. Riley Securities	Buy
2022-04-05	Ripresa	B. Riley Securities	Buy
2021-03-18	Iniziato	Lake Street	Buy
2020-07-17	Iniziato	B. Riley FBR	Buy

Mostra tutto

Clearpoint Neuro Inc Borsa (CLPT) Ultime notizie

Mar 30, 2026

Clearpoint Neuro, Valneva, Rocket Lab and other big stocks moving lower in Wednesday's pre-market session - MSN

Mar 30, 2026

Will ClearPoint Neuro Inc benefit from current market trends2026 Recap & Accurate Entry and Exit Point Alerts - baoquankhu1.vn

Mar 30, 2026

ClearPoint Neuro (CLPT) price target decreased by 10.71% to 25.50 - MSN

Mar 30, 2026

Mar 29, 2026

ClearPoint Neuro, Inc. (NASDAQ:CLPT) Short Interest Up 29.0% in March - MarketBeat

Mar 29, 2026

Mar 28, 2026

Can ClearPoint Neuro Inc be the next market leaderEarnings Recap Report & Growth Focused Stock Reports - baoquankhu1.vn

Mar 28, 2026

What are the future prospects of ClearPoint Neuro Inc2026 Final Week & Stock Market Timing Techniques - baoquankhu1.vn

Mar 28, 2026

Mar 26, 2026

Vanguard amendment shows 0% stake in ClearPoint Neuro (CLPT) after realignment - Stock Titan

Mar 26, 2026

Mar 23, 2026

ClearPoint Neuro (CLPT) moves 8.1% higher: Will this strength last? - MSN

Mar 23, 2026

Why The ClearPoint Neuro (CLPT) Story Is Shifting After New Partner And FDA Updates - Yahoo Finance

Mar 23, 2026

Mar 22, 2026

ClearPoint Neuro plunges as FY26 guidance falls below analysts' estimates - MSN

Mar 22, 2026

Trading Systems Reacting to (CLPT) Volatility - news.stocktradersdaily.com

Mar 22, 2026

Mar 20, 2026

ClearPoint Neuro (CLPT) CEO exercises options and holds all shares - Stock Titan

Mar 20, 2026

Fundamentals Check: Will ClearPoint Neuro Inc benefit from current market trendsInsider Selling & Weekly Momentum Stock Picks - baoquankhu1.vn

Mar 20, 2026

Mar 19, 2026

Analysts Are Bullish on Top Healthcare Stocks: ClearPoint Neuro (CLPT), Xtant Medical Holdings (XTNT) - The Globe and Mail

Mar 19, 2026

ClearPoint Neuro, Inc. (NASDAQ:CLPT) Q4 2025 Earnings Call Transcript - Insider Monkey

Mar 19, 2026

Clearpoint Neuro’s IRRAS Acquisition: Integration Risks Threaten Promised Scale and Synergies - TipRanks

Mar 19, 2026

Mar 18, 2026

ClearPoint Neuro FY 2025 Revenue Growth Reinforces Bullish Narratives Despite Persistent EPS Losses - simplywall.st

Mar 18, 2026

Intuitive Surgical Stock: Buy, Sell, or Hold? - AOL.com

Mar 18, 2026

ClearPoint Neuro Reports Record 2025 Results, Expands Growth Outlook - The Globe and Mail

Mar 18, 2026

ClearPoint Neuro Q4 Earnings Call Highlights - MarketBeat

Mar 18, 2026

ClearPoint Neuro (NASDAQ:CLPT) Given New $20.00 Price Target at B. Riley Financial - MarketBeat

Mar 18, 2026

ClearPoint Neuro (CLPT) Sees Raised Price Target from B. Riley S - GuruFocus

Mar 18, 2026

Clearpoint Neuro, Valneva, Rocket Lab And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga

Mar 18, 2026

B. Riley Raises Price Target on ClearPoint Neuro to $20 From $18, Keeps Buy Rating - marketscreener.com

Mar 18, 2026

ClearPoint Neuro, Inc. Q4 2025 earnings preview - MSN

Mar 18, 2026

ClearPoint Neuro (CLPT) Surpasses Q4 Revenue Expectations with S - GuruFocus

Mar 18, 2026

Clearpoint Neuro earnings missed by $0.08, revenue topped estimates - Investing.com Canada

Mar 18, 2026

ClearPoint Neuro outlines $52M–$56M 2026 revenue target as company advances growth strategy and integrates IRRAS acquisition - MSN

Mar 17, 2026

Clearpoint Neuro Charts Aggressive Growth Amid Rising Costs - TipRanks

Mar 17, 2026

ClearPoint Neuro (CLPT) Projects Strong Growth for 2026 - GuruFocus

Mar 17, 2026

Earnings call transcript: ClearPoint Neuro Q4 2025 sees revenue growth, stock up By Investing.com - Investing.com South Africa

Mar 17, 2026

Earnings call transcript: ClearPoint Neuro Q4 2025 sees revenue growth, stock up - Investing.com Australia

Mar 17, 2026

ClearPoint Neuro 2025 Results & 2026 Growth Strategy for Neuro EcosystemNews and Statistics - IndexBox

Mar 17, 2026

ClearPoint Neuro (CLPT) Quarterly Earnings Conference Call Transcript - Bitget

Mar 17, 2026

CLPT: Record 2025 growth and IRRAS integration set the stage for double-digit expansion in 2026 - TradingView

Mar 17, 2026

ClearPoint Neuro (CLPT) Earnings Call Transcript - The Globe and Mail

Mar 17, 2026